Dynamics of myocardial damage markers in patients with infective endocarditis complicated by acute heart failure
PDF (Українська)

Keywords

cardiac dysfunction
dynamics of biomarker levels
cardiovascular damage
cardiac surgery
perioperative period

How to Cite

Koltunova, H., & Chyzh, K. (2024). Dynamics of myocardial damage markers in patients with infective endocarditis complicated by acute heart failure. Medicine Today and Tomorrow, 93(4). https://doi.org/10.35339/msz.2024.93.4.koc

Abstract

In press

Patients with Infective Endocarditis (IE) complicated by Acute Heart Failure (AHF) require immediate cardiac surgery. Detection of high levels of N-terminal B-type natriuretic propeptide (NT-proBNP) and Cardiac Troponin I (cTnI) may facilitate early recognition of such patients. The aim of the study was to determine the dynamics of markers of myocardial injury in 75 patients with IE hospitalised at the Amosov National Institute of Cardiovascular Surgery in the period from 2019 to 2023. The diagnosis of IE was made according to the Duke criteria, and all patients were classified as class IV according to the New York Heart Association (NYHA) functional classification. The examination data are shown in the form (Me[Q1;Q3]). For an in-depth study of myocardial damage in heart failure, the levels of NT-proBNP and cTnI were analysed at five stages: at the beginning of surgery, after completion of cardiopulmonary bypass, on days2, 7, and 14 of the postoperative period. In patients with HF, preoperative NT-proBNP levels were NT-proBNP – 8110.0 (2091.4;17738.3) pg/ml; and cTnI – 0.2 (0.1;0.74) ng/ml. After the operation, NT-proBNP and cTnI levels increased to 8778.6 pg/mL (3798.0;15674.9) and 4.83 ng/mL (2.36;9.61), respectively. The median duration of artificial lung ventilation was 21 hours (14;29). According to the results of the data analysis, patients with a duration of artificial lung ventilation (ALV) of 29 hours were included in the third quartile. The total duration of inpatient treatment was 19 days, and the ICU stay for patients with IE complicated by AHF was 7 (5;11) days. The total duration of inpatient treatment was 19 (14;22) days. The results showed an increase in cTnI level with a simultaneous decrease in NT-proBNP after surgery, followed by a steady increase in both markers in patients with IE complicated by AHF.

Keywords: cardiac dysfunction, dynamics of biomarker levels, cardiovascular damage, cardiac surgery, perioperative period.

https://doi.org/10.35339/msz.2024.93.4.koc
PDF (Українська)

References

Bertolino L, Ursi MP, Iossa D, Karruli A, D'Amico F, Zampino R, et al.; Monaldi Hospital Cardiovascular Infection Study Group. Dissecting the correlates of N-terminal prohormone brain natriuretic peptide in acute infective endocarditis. Infection. 2022;50(6):1465-74. DOI: 10.1007/s15010-022-01813-y. PMID: 35430641.

Siciliano RF, Gualandro DM, Bittencourt MS, Paixao M, Marcondes-Braga F, Soeiro AM, al. Biomarkers for prediction of mortality in left-sided infective endocarditis. Int J Infect Dis. 2020;96:25-30. DOI: 10.1016/j.ijid.2020.03.009. PMID: 32169690.

Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al.; ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis: Developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM). European Heart Journal. 2023;44(39):3948-4042. DOI: 10.1093/eurheartj/ehad193.

McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al.; ESC Scientific Document Group. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2023;44(37):3627-39. DOI: 10.1093/eurheartj/ehad195.

Abellas Sequeiros M, Moya Mur JL, Navas E, Martin Davila MP, Del Prado S, Lorente Ros A, et al. Prognostic significance of biomarkers in infective endocarditis. European Journal of Heart Failure. 2019;21:274.

Postigo A, Bermejo J, Muñoz P, Valerio M, Marín M, Pinilla B, et al. Troponin elevation is very common in patients with infective endocarditis and is associated with a poor outcome. International Journal of Cardiology. 2020;307:82-6. DOI: 10.1016/j.ijcard.2020.02.029. PMID: 32081472.

Lorson W, Veve MP, Heidel E, Shorman MA. Elevated troponin level as a predictor of inpatient mortality in patients with infective endocarditis in the Southeast United States. BMC Infectious Diseases. 2020;20(1):24. DOI: 10.1186/s12879-019-4755-z. PMID: 31914949.

Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, et al. Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization. Circulation. 2018;137(12):1221-32. DOI: 0.1161/CIRCULATIONAHA.117.030114. PMID: 29459461

Wei XB, Liu YH, He PC, Yu DQ, Zhou YL, Tan N, et al. Prognostic value of N-terminal prohormone brain natriuretic peptide for in-hospital and long-term outcomes in patients with infective endocarditis. European Journal of Preventive Cardiology. 2017;24(7):676-84. DOI 10.1177/2047487317697137.PMID: 28372550.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.